Medical Research
(H05)
IRS Verified
DX Registered
NATIONAL PERT CONSORTIUM INC
CharityAI™ Score
Not yet evaluated
Mission Statement
Our mission is to enable the best care for pulmonary embolism (PE blood clots) worldwide, ensuring that all individuals, regardless of geographic location or available resources, have access to high-quality care. We achieve this by educating healthcare providers and the public, increasing awareness, disseminating best practices, and empowering providers and patients. Through these efforts, we aim to improve outcomes, reduce disparities, and save lives.
Financial Overview — FY 2023
$2.0M
Total Revenue
$1.8M
Total Expenses
N/A
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$336K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.0M | $1.8M | N/A | — | 3 |
| 2022 | $1.9M | $1.7M | N/A | — | 5 |
| 2021 | $1.4M | $1.1M | N/A | — | 5 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.